Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$9.95 - $12.27 $35,083 - $43,264
-3,526 Closed
0 $0
Q4 2021

Jan 06, 2022

SELL
$12.09 - $14.68 $2,901 - $3,523
-240 Reduced 6.37%
3,526 $48,000
Q3 2021

Oct 12, 2021

SELL
$13.25 - $15.13 $19,994 - $22,831
-1,509 Reduced 28.61%
3,766 $51,000
Q2 2021

Jul 16, 2021

BUY
$12.97 - $16.15 $9,740 - $12,128
751 Added 16.6%
5,275 $75,000
Q1 2021

Apr 27, 2021

SELL
$13.59 - $18.54 $27 - $37
-2 Reduced 0.04%
4,524 $63,000
Q4 2020

Jan 27, 2021

BUY
$14.3 - $18.74 $64,721 - $84,817
4,526 New
4,526 $85,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $16B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Tarbox Family Office, Inc. Portfolio

Follow Tarbox Family Office, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tarbox Family Office, Inc. with notifications on news.